Analyst firms · BofA Securities · RXST
BofA Securities RXST price target and rating history
RxSight Inc. (RXST) · Health Care
BofA Securities rates RxSight Inc. (RXST) Underperform with a $22 price target, as of its latest action on Apr 3, 2025. It has published 3 rating actions on RXST since August 2021, including 0 upgrades and 1 downgrade.
- Current rating
- Underperform
- Price target
- $22
- Median target, all firms
- Too few
- Actions on RXST
- 3
BofA Securities price target on RXST
Every BofA Securities rating on RXST
- Apr 3, 2025
- Aug 24, 2021
- Aug 24, 2021
Questions about BofA Securities and RXST
- What is BofA Securities's price target for RXST?
- BofA Securities's latest stated price target for RxSight Inc. (RXST) is $22, from its action on Apr 3, 2025.
- What is BofA Securities's rating on RXST?
- BofA Securities rates RXST Underperform, a bearish rating, as of Apr 3, 2025.
- When did BofA Securities last change its view on RXST?
- On Apr 3, 2025, BofA Securities downgrades to Underperform from Buy, price target $36 to $22.
More RXST rating histories
All BofA Securities ratingsRXST news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.